347 related articles for article (PubMed ID: 25672396)
1. Generation of mouse pluripotent stem cell-derived proliferating myeloid cells as an unlimited source of functional antigen-presenting cells.
Zhang R; Liu TY; Senju S; Haruta M; Hirosawa N; Suzuki M; Tatsumi M; Ueda N; Maki H; Nakatsuka R; Matsuoka Y; Sasaki Y; Tsuzuki S; Nakanishi H; Araki R; Abe M; Akatsuka Y; Sakamoto Y; Sonoda Y; Nishimura Y; Kuzushima K; Uemura Y
Cancer Immunol Res; 2015 Jun; 3(6):668-77. PubMed ID: 25672396
[TBL] [Abstract][Full Text] [Related]
2. TAP-deficient human iPS cell-derived myeloid cell lines as unlimited cell source for dendritic cell-like antigen-presenting cells.
Haruta M; Tomita Y; Yuno A; Matsumura K; Ikeda T; Takamatsu K; Haga E; Koba C; Nishimura Y; Senju S
Gene Ther; 2013 May; 20(5):504-13. PubMed ID: 22875043
[TBL] [Abstract][Full Text] [Related]
3. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.
Bodey B; Bodey B; Kaiser HE
In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303
[TBL] [Abstract][Full Text] [Related]
4. Sequential delivery of maturation stimuli increases human dendritic cell IL-12 production and enhances tumor antigen-specific immunogenicity.
Kalady MF; Onaitis MW; Emani S; Abdel-Wahab Z; Tyler DS; Pruitt SK
J Surg Res; 2004 Jan; 116(1):24-31. PubMed ID: 14732346
[TBL] [Abstract][Full Text] [Related]
5. Interferon gamma stimulates cellular maturation of dendritic cell line DC2.4 leading to induction of efficient cytotoxic T cell responses and antitumor immunity.
He T; Tang C; Xu S; Moyana T; Xiang J
Cell Mol Immunol; 2007 Apr; 4(2):105-11. PubMed ID: 17484804
[TBL] [Abstract][Full Text] [Related]
6. Generation of GM-CSF-producing antigen-presenting cells that induce a cytotoxic T cell-mediated antitumor response.
Mashima H; Zhang R; Kobayashi T; Hagiya Y; Tsukamoto H; Liu T; Iwama T; Yamamoto M; Lin C; Nakatsuka R; Mishima Y; Watanabe N; Yamada T; Senju S; Kaneko S; Idiris A; Nakatsura T; Ohdan H; Uemura Y
Oncoimmunology; 2020 Sep; 9(1):1814620. PubMed ID: 33457097
[TBL] [Abstract][Full Text] [Related]
7. Preparation of fully activated dendritic cells capable of priming tumor-specific cytotoxic T lymphocytes in patients with metastatic cancer using penicillin-killed streptococcus pyogenes (OK432) and anti-CD40 antibody.
Kontani K; Teramoto K; Ozaki Y; Sawai S; Tezuka N; Ishida H; Kajino K; Fujino S; Yamauchi A; Taguchi O; Kannagi R; Yokomise H; Ogasawara K
Oncol Rep; 2007 Apr; 17(4):895-902. PubMed ID: 17342333
[TBL] [Abstract][Full Text] [Related]
8. In vitro immunization of patient T cells with autologous bone marrow antigen presenting cells pulsed with tumor lysates.
Coulon V; Ravaud A; Gaston R; Delaunay M; Pariente JL; Verdier D; Scrivante V; Gualde N
Int J Cancer; 2000 Dec; 88(5):783-90. PubMed ID: 11072249
[TBL] [Abstract][Full Text] [Related]
9. In vivo programming of tumor antigen-specific T lymphocytes from pluripotent stem cells to promote cancer immunosurveillance.
Lei F; Zhao B; Haque R; Xiong X; Budgeon L; Christensen ND; Wu Y; Song J
Cancer Res; 2011 Jul; 71(14):4742-7. PubMed ID: 21628492
[TBL] [Abstract][Full Text] [Related]
10. Cognate interactions between memory T cells and tumor antigen-presenting dendritic cells from bone marrow of breast cancer patients: bidirectional cell stimulation, survival and antitumor activity in vivo.
Bai L; Beckhove P; Feuerer M; Umansky V; Choi C; Solomayer FS; Diel IJ; Schirrmacher V
Int J Cancer; 2003 Jan; 103(1):73-83. PubMed ID: 12455056
[TBL] [Abstract][Full Text] [Related]
11. Polyriboinosinic polyribocytidylic acid (poly(I:C)) induces stable maturation of functionally active human dendritic cells.
Verdijk RM; Mutis T; Esendam B; Kamp J; Melief CJ; Brand A; Goulmy E
J Immunol; 1999 Jul; 163(1):57-61. PubMed ID: 10384099
[TBL] [Abstract][Full Text] [Related]
12. Cytokines in the generation and maturation of dendritic cells: recent advances.
Zou GM; Tam YK
Eur Cytokine Netw; 2002; 13(2):186-99. PubMed ID: 12101074
[TBL] [Abstract][Full Text] [Related]
13. Strategies for antigen loading of dendritic cells to enhance the antitumor immune response.
Strome SE; Voss S; Wilcox R; Wakefield TL; Tamada K; Flies D; Chapoval A; Lu J; Kasperbauer JL; Padley D; Vile R; Gastineau D; Wettstein P; Chen L
Cancer Res; 2002 Mar; 62(6):1884-9. PubMed ID: 11912169
[TBL] [Abstract][Full Text] [Related]
14. Characterization of dendritic cells and macrophages generated by directed differentiation from mouse induced pluripotent stem cells.
Senju S; Haruta M; Matsunaga Y; Fukushima S; Ikeda T; Takahashi K; Okita K; Yamanaka S; Nishimura Y
Stem Cells; 2009 May; 27(5):1021-31. PubMed ID: 19415766
[TBL] [Abstract][Full Text] [Related]
15. Immunogenic Dendritic Cell Generation from Pluripotent Stem Cells by Ectopic Expression of Runx3.
Takacs E; Boto P; Simo E; Csuth TI; Toth BM; Raveh-Amit H; Pap A; Kovács EG; Kobolak J; Benkö S; Dinnyes A; Szatmari I
J Immunol; 2017 Jan; 198(1):239-248. PubMed ID: 27852743
[TBL] [Abstract][Full Text] [Related]
16. Human dendritic cells, pulsed with either melanoma tumor cell lysates or the gp100 peptide(280-288), induce pairs of T-cell cultures with similar phenotype and lytic activity.
Abdel-Wahab Z; DeMatos P; Hester D; Dong XD; Seigler HF
Cell Immunol; 1998 May; 186(1):63-74. PubMed ID: 9637766
[TBL] [Abstract][Full Text] [Related]
17. Retrovirally transduced bone marrow-derived dendritic cells require CD4+ T cell help to elicit protective and therapeutic antitumor immunity.
De Veerman M; Heirman C; Van Meirvenne S; Devos S; Corthals J; Moser M; Thielemans K
J Immunol; 1999 Jan; 162(1):144-51. PubMed ID: 9886380
[TBL] [Abstract][Full Text] [Related]
18. Directed differentiation of human embryonic stem cells into functional dendritic cells through the myeloid pathway.
Slukvin II; Vodyanik MA; Thomson JA; Gumenyuk ME; Choi KD
J Immunol; 2006 Mar; 176(5):2924-32. PubMed ID: 16493050
[TBL] [Abstract][Full Text] [Related]
19. Adenovirus-mediated CD40 ligand gene-engineered dendritic cells elicit enhanced CD8(+) cytotoxic T-cell activation and antitumor immunity.
Liu Y; Zhang X; Zhang W; Chen Z; Chan T; Ali K; Jia Z; Xiang J
Cancer Gene Ther; 2002 Feb; 9(2):202-8. PubMed ID: 11857039
[TBL] [Abstract][Full Text] [Related]
20. Multiple antigen-targeted immunotherapy with alpha-galactosylceramide-loaded and genetically engineered dendritic cells derived from embryonic stem cells.
Fukushima S; Hirata S; Motomura Y; Fukuma D; Matsunaga Y; Ikuta Y; Ikeda T; Kageshita T; Ihn H; Nishimura Y; Senju S
J Immunother; 2009 Apr; 32(3):219-31. PubMed ID: 19242378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
